論文種別	原著(症例報告除く)
言語種別	英語
査読の有無	査読あり
表題	Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–positive, HER2-negative advanced or metastatic breast cancer
掲載誌名	正式名：Breast cancer 略　 称：Breast Cancer ISSNコード：13406868/18804233
掲載区分	国外
巻・号・頁	32(4),pp.841-856
著者・共著者	Tetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki, Yukiko Kajiwara, Mitsugu Yamamoto, Ken-ichi Watanabe, Masami Tsukabe, Fumie Fujisawa, Shigenori E. Nagai, Nobuhiro Shibata, Chiya Oshiro, Hiroko Bando, Nobuyuki Tsunoda, Kazuhiko Yamagami, Kei Koizumi, Masahiro Takada, Naoko Toriguchi, Nobuyuki Sekine, Tsutomu Kawaguchi, Shigehira Saji, Yasuaki Sagara, Satoshi Morita, Norikazu Masuda
発行年月	2025/07
DOI	10.1007/s12282-025-01713-7
PMID	40392524